Galectin-3 Inhibition in COVID-19.
作者信息
Reddy Kiran, Nichol Alistair, McAuley Daniel F
机构信息
School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Belfast, Northern Ireland.
Regional Intensive Care Unit Royal Victoria Hospital Belfast, Northern Ireland.
出版信息
Am J Respir Crit Care Med. 2023 Jan 15;207(2):118-120. doi: 10.1164/rccm.202209-1758ED.
Abstract
摘要
相似文献
1
Galectin-3 Inhibition in COVID-19.
Am J Respir Crit Care Med. 2023 Jan 15;207(2):118-120. doi: 10.1164/rccm.202209-1758ED.
2
Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.
Clin Lab. 2022 Dec 1;68(12). doi: 10.7754/Clin.Lab.2022.220134.
3
Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study.
Biomolecules. 2021 Aug 1;11(8):1136. doi: 10.3390/biom11081136.
4
Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?
Turk J Med Sci. 2021 Oct 21;51(5):2256-2262. doi: 10.3906/sag-2102-202.
5
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19.
Jpn J Infect Dis. 2021 Nov 22;74(6):530-536. doi: 10.7883/yoken.JJID.2021.020. Epub 2021 Mar 31.
6
Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3.
Exp Biol Med (Maywood). 2020 Oct;245(16):1425-1427. doi: 10.1177/1535370220953771. Epub 2020 Aug 24.
7
High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia.
Int J Mol Sci. 2021 May 7;22(9):4978. doi: 10.3390/ijms22094978.
8
Serum galectin-3 and aldosterone: potential biomarkers of cardiac complications in patients with COVID-19.
Minerva Endocrinol (Torino). 2022 Sep;47(3):270-278. doi: 10.23736/S2724-6507.22.03789-7. Epub 2022 Mar 10.
9
Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19.
Cytokine. 2022 Oct;158:155970. doi: 10.1016/j.cyto.2022.155970. Epub 2022 Jul 28.
10
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Clin Chim Acta. 2015 May 20;445:155-60. doi: 10.1016/j.cca.2015.03.033. Epub 2015 Apr 4.
引用本文的文献
1
Galectin-3 regulates erythropoiesis and enhances the immunoregulatory properties of CD71+ erythroid cells across developmental stages.
J Immunol. 2025 Jun 1;214(6):1202-1218. doi: 10.1093/jimmun/vkaf020.
2
Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4/MyD88/NF-κB pathway.
Cell Death Discov. 2024 Feb 20;10(1):92. doi: 10.1038/s41420-024-01859-x.
3
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.
Microbiol Spectr. 2023 Sep 7;11(5):e0125623. doi: 10.1128/spectrum.01256-23.
4
The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host-Pathogen Interactions.
Int J Mol Sci. 2023 Jun 1;24(11):9617. doi: 10.3390/ijms24119617.
本文引用的文献
1
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).
Am J Respir Crit Care Med. 2023 Jan 15;207(2):138-149. doi: 10.1164/rccm.202203-0477OC.
2
SARS-CoV-2 pathogenesis.
Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.
3
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients.
Sci Rep. 2022 Feb 3;12(1):1856. doi: 10.1038/s41598-022-05968-4.
4
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
5
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
6
YKL-40 as a new promising prognostic marker of severity in COVID infection.
Crit Care. 2021 Feb 16;25(1):66. doi: 10.1186/s13054-020-03383-7.
7
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider.
Front Immunol. 2020 Aug 18;11:2069. doi: 10.3389/fimmu.2020.02069. eCollection 2020.
8
COVID19 coagulopathy in Caucasian patients.
Br J Haematol. 2020 Jun;189(6):1044-1049. doi: 10.1111/bjh.16749. Epub 2020 May 17.
9
The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens.
Mediators Inflamm. 2017;2017:9247574. doi: 10.1155/2017/9247574. Epub 2017 May 11.
10
The Predictive Value of Plasma Galectin-3 for Ards Severity and Clinical Outcome.
Shock. 2017 Mar;47(3):331-336. doi: 10.1097/SHK.0000000000000757.
Zotero 插件